(Q35991734)

11 August 2017

A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd. (English)

1 reference

11 August 2017

1 reference

Bratherton DG

1

1 reference

11 August 2017

Brown CH

2

1 reference

11 August 2017

Buchanan R

3

1 reference

11 August 2017

Hall V

4

1 reference

11 August 2017

Kingsley Pillers EM

5

1 reference

11 August 2017

Wheeler TK

6

1 reference

11 August 2017

Williams CJ

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1984

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

50

1 reference

11 August 2017

2

1 reference

11 August 2017

199-205

1 reference

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976875

Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976875

Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976875

Tamoxifen in advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976875

Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976875

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

11 July 2018

1 reference

12 December 2020

Trial of tamoxifen at a dose of 40 mg daily after disease progression during tamoxifen therapy at a dose of 20 mg daily

1 reference

12 December 2020

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial

1 reference

12 December 2020

Measurement of tamoxifen in serum by thin-layer densitometry

1 reference

12 December 2020

Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers

1 reference

12 December 2020

Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function

1 reference

12 December 2020

Chemotherapy and Tamoxifen for Breast Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1984.163

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

6380554

1 reference